We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Bioelectronic Therapy Device Exercises Heart Muscle

By HospiMedica International staff writers
Posted on 22 Jul 2019
A novel electroceutical device readjusts the myocardial electrical gradient in order to strengthen the weakened heart muscle of cardiomyopathy patients.

Under development by Berlin Heals (Berlin, Germany), C-MIC cardiac microcurrent therapy is based on an implanted pulse generator that exercises the heart muscle using electricity, thus stimulating it to renew itself. More...
In a minimally invasive procedure, a small microcurrent pulse generator is implanted via two small incisions. Two electrodes exit the pulse generator, one taking the form of an extensive patch on the outside of the heart muscle, while the other is placed inside the left ventricle. The system is designed to stimulate the affected heart muscle, causing it to regenerate.

In a preclinical study at Hannover Medical School (Germany) involving 12 sheep with chronic systolic heart failure, the continuous microcurrent therapy was associated with a strong improvement of left ventricular ejection fraction (LVEF), indicating reversal of cardiac remodeling and reduced myocardial inflammation. A first in human study of the C-MIC device at the Medical University of Vienna (MedUni; Austria) revealed that after three months, the first patient treated showing initial signs of regeneration. The study was published in the April 2019 issue of The Journal of Heart and Lung Transplantation.

“The preliminary findings bring us real hope for cardiomyopathy patients. Microcurrent regeneration could bring us a step closer to the dream of being able to regenerate damaged organs,” said lead author Dominik Wiedemann, MD, of the MedUni division of cardiac surgery. “Particularly in times when donor organs are scarce, it is important to develop new effective treatment techniques to avoid major operations such as heart transplants as much as possible, as well as the subsequent immunosuppression that goes with them."

In dilative cardiomyopathy, the heart muscle becomes pathologically enlarged so that it can no longer contract sufficiently. Current treatments attempt to stabilize such heart failure patients for as long as possible by means of optimized drug treatment or specialized pacemakers. The treatment of last resort for terminal heart failure is a heart transplant or mechanical replacement using a left ventricular assist device (LVAD).

Related Links:
Berlin Heals
Hannover Medical School
Medical University of Vienna



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Infant Resuscitator
Easypuff
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.